He further recalled that 79% of the adult population have already been vaccinated with a first dose of COVID-19 vaccines whereas 65% have completed both doses, which according to him is progressing at a fast pace within the last few weeks.
DrKailesh Jagutpalexpressed satisfaction as to the vaccination programme which is being carried out in an organised manner by the dedicated vaccination team which is following all the steps put in place for the inoculation. He further pointed out that well-established procedures have been devised for the vaccination process starting with the consent form till the monitoring of any reaction of the vaccine on the person.
Healso announced that the Johnson & Johnson vaccines, which require an individual to have a single dose, have also kick-started, this morning, atthe Rivière des Anguilles COVID-19 Vaccination Centre as well as in all Vaccination Centres across the country. He reassured the population that everyone will have the opportunity to avail of the vaccines and appealed to them to avoid crowd gathering at Vaccination Centres.
Regarding the procurement of vaccines, DrJagutpal underlined that 500 000 doses of Sinopharm vaccines will be received shortly in addition to other vaccines from the African Union under the COVAX facility. He further stated that people with comorbidities will be given priority for the vaccination as they are more vulnerable to the COVID-19. He added that the Vaccination Centres in Regional Hospitals will remain open to the public.
For his part, the Chief Health Promotion and Research Coordinator of the Non-Communicable Diseases and Health Promotion Unit at theMinistry of Health and Wellness, Dr Sudhir Kowlessur, clarified that with the different vaccines available in Mauritius, the inoculation of two different types of COVID-19 vaccines, to be determined as per doctors’ instructions only, are not authorised in Mauritius adding that such practices may lead to severe sanctions. And at date, he said, two such cases have been reported to the Police.
Distributed by APO Group on behalf of Republic of Mauritius.